Vaccine Trials Target Leading Cause of Diarrheal Disease Deaths

Why it matters locally: The development of a vaccine against Shigella could have a notable impact on public health initiatives within North Carolina, particularly in reducing diarrheal disease incidence among vulnerable populations, including young children.

Medical researchers are conducting trials for a new vaccine designed to combat Shigella bacteria. Shigella represents a primary cause of diarrheal disease globally. Diarrheal diseases result in over one million deaths each year. Children under the age of five account for nearly half of these fatalities. The development of this vaccine offers a potential intervention against this widespread health issue.